BOLD vs HCA · P/E 0.1, $24.6M cap vs P/E 17, rev $75.60B
Boundless Bio, Inc. Common Stock (BOLD) versus HCA Holdings Inc (HCA) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
Not investment advice. Open the BOLD and HCA stock pages for the full models.
Not investment advice.